Pembrolizumab-induced hepatitis: diagnosis and treatment

J Dtsch Dermatol Ges. 2017 Sep;15(9):933-935. doi: 10.1111/ddg.13037.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use
  • Hepatitis / diagnosis
  • Hepatitis / drug therapy
  • Hepatitis / etiology*
  • Humans
  • Male
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Neoplasms / drug therapy*
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Glucocorticoids
  • pembrolizumab
  • Methylprednisolone